Correlations between personality traits, personality disorders, and immunometabolic markers.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 May 2024
21 May 2024
Historique:
received:
01
09
2023
accepted:
14
05
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
21
5
2024
Statut:
epublish
Résumé
Evidence links immune system alterations to major psychiatric disorders. The few previous studies on personality traits or personality disorders (PDs) indicate that immunometabolic dysregulation may be prevalent in this population. This study aimed to investigate relationships between personality traits, PDs, and immunometabolic markers in peripheral blood. We hypothesized that neuroticism would be correlated with elevated leptin. Participants were recruited as young adults seeking care for general psychiatric disorders. They responded to a personality inventory and were assessed for PDs, and reevaluated again at a 12 years follow-up. Blood samples were collected at the follow-up and analyzed for 29 immunometabolic markers. A positive correlation was found between the personality trait neuroticism and leptin (ρ = 0.31, p = 0.02). An exploratory analysis also revealed a positive correlation between brain-derived neurotrophic factor (ρ = 0.36, p < 0.01) and neuroticism. These findings remained after adjusting for other variables in general linear models. There were no relationships between PDs and any immunometabolic markers. Results both confirm previous findings of correlations between the immunometabolic system and personality traits and suggest directions for future research.
Identifiants
pubmed: 38773198
doi: 10.1038/s41598-024-62214-9
pii: 10.1038/s41598-024-62214-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11635Informations de copyright
© 2024. The Author(s).
Références
Goldsmith, D. R., Rapaport, M. H. & Miller, B. J. A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 21, 1696–1709. https://doi.org/10.1038/mp.2016.3 (2016).
doi: 10.1038/mp.2016.3
pubmed: 26903267
pmcid: 6056174
Köhler, C. A. et al. Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Acta Psychiatr. Scand. 135, 373–387. https://doi.org/10.1111/acps.12698 (2017).
doi: 10.1111/acps.12698
pubmed: 28122130
Toenders, Y. J. et al. Inflammation and depression in young people: A systematic review and proposed inflammatory pathways. Mol. Psychiatry 27, 315–327. https://doi.org/10.1038/s41380-021-01306-8 (2022).
doi: 10.1038/s41380-021-01306-8
pubmed: 34635789
Suvisaari, J. et al. Mental disorders in young adulthood. Psychol. Med. 39, 287–299. https://doi.org/10.1017/s0033291708003632 (2009).
doi: 10.1017/s0033291708003632
pubmed: 18507875
Newton-Howes, G., Clark, L. A. & Chanen, A. Personality disorder across the life course. Lancet 385, 727–734. https://doi.org/10.1016/s0140-6736(14)61283-6 (2015).
doi: 10.1016/s0140-6736(14)61283-6
pubmed: 25706218
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (American Psychiatric Association, 2013).
doi: 10.1176/appi.books.9780890425596
Spangenberg, H., Sandholm, S., Ramklint, M. & Ramirez, A. Moving in together, marriage, and motherhood: A follow up study of relationships in psychiatric patients with personality disorders. Personal. Ment. Health 15, 186–197. https://doi.org/10.1002/pmh.1507 (2021).
doi: 10.1002/pmh.1507
pubmed: 33660390
Korkeila, J. et al. Early retirement from work among employees with a diagnosis of personality disorder compared to anxiety and depressive disorders. Eur. Psychiatry 26, 18–22. https://doi.org/10.1016/j.eurpsy.2009.12.022 (2011).
doi: 10.1016/j.eurpsy.2009.12.022
pubmed: 20541917
Digman, J. Personality structure: Emergence of the five-factor model. Annu. Rev. Psychol. 41, 417–440 (1990).
doi: 10.1146/annurev.ps.41.020190.002221
Ekselius, L., Hetta, J. & von Knorring, L. Relationship between personality traits as determined by means of the Karolinska Scales of Personality (KSP) and personality disorders according to DSM-III-R. Personal. Individ. Differ. 16, 589–595. https://doi.org/10.1016/0191-8869(94)90186-4 (1994).
doi: 10.1016/0191-8869(94)90186-4
Syk, M., Isaksson, J., Rasmusson, A. J., Ekselius, L. & Cunningham, J. L. Neuroticism is positively associated with leptin/adiponectin ratio, leptin and IL-6 in young adults. Sci. Rep. 11, 9690. https://doi.org/10.1038/s41598-021-89251-y (2021).
doi: 10.1038/s41598-021-89251-y
pubmed: 33963214
pmcid: 8105321
Sutin, A. R. et al. High neuroticism and low conscientiousness are associated with interleukin-6. Psychol. Med. 40, 1485–1493. https://doi.org/10.1017/s0033291709992029 (2010).
doi: 10.1017/s0033291709992029
pubmed: 19995479
Wagner, E. N. et al. Associations of personality traits with chronic low-grade inflammation in a Swiss community sample. Front. Psychiatry 10, 819. https://doi.org/10.3389/fpsyt.2019.00819 (2019).
doi: 10.3389/fpsyt.2019.00819
pubmed: 31798472
pmcid: 6863063
Mengelkoch, S., Gassen, J., Corrigan, E. K. & Hill, S. E. Exploring the links between personality and immune function. Personal. Individ. Differ. https://doi.org/10.1016/j.paid.2021.111179 (2022).
doi: 10.1016/j.paid.2021.111179
Luchetti, M., Barkley, J. M., Stephan, Y., Terracciano, A. & Sutin, A. R. Five-factor model personality traits and inflammatory markers: New data and a meta-analysis. Psychoneuroendocrinology 50, 181–193. https://doi.org/10.1016/j.psyneuen.2014.08.014 (2014).
doi: 10.1016/j.psyneuen.2014.08.014
pubmed: 25233337
pmcid: 4544833
Sutin, A. R. et al. Personality traits and leptin. Psychosom. Med. 75, 505–509. https://doi.org/10.1097/PSY.0b013e3182919ff4 (2013).
doi: 10.1097/PSY.0b013e3182919ff4
pubmed: 23697464
pmcid: 4511923
Milaneschi, Y., Lamers, F., Bot, M., Drent, M. L. & Penninx, B. W. Leptin dysregulation is specifically associated with major depression with atypical features: Evidence for a mechanism connecting obesity and depression. Biol. Psychiatry 81, 807–814. https://doi.org/10.1016/j.biopsych.2015.10.023 (2017).
doi: 10.1016/j.biopsych.2015.10.023
pubmed: 26742925
Syk, M. et al. Plasma levels of leptin and adiponectin and depressive symptoms in young adults. Psychiatry Res. 272, 1–7. https://doi.org/10.1016/j.psychres.2018.11.075 (2019).
doi: 10.1016/j.psychres.2018.11.075
pubmed: 30562581
Zupancic, M. L. & Mahajan, A. Leptin as a neuroactive agent. Psychosom. Med. 73, 407–414. https://doi.org/10.1097/PSY.0b013e31821a196f (2011).
doi: 10.1097/PSY.0b013e31821a196f
pubmed: 21597032
Stephan, Y., Sutin, A. R., Luchetti, M., Canada, B. & Terracciano, A. Personality and HbA1c: Findings from six samples. Psychoneuroendocrinology 120, 104782. https://doi.org/10.1016/j.psyneuen.2020.104782 (2020).
doi: 10.1016/j.psyneuen.2020.104782
pubmed: 32659693
pmcid: 9837711
Tanios, V., Terracciano, A., Luchetti, M., Stephan, Y. & Sutin, A. R. Personality traits at age 16 and risk of metabolic syndrome at age 46. J. Psychosom. Res. https://doi.org/10.1016/j.jpsychores.2022.110744 (2022).
doi: 10.1016/j.jpsychores.2022.110744
pubmed: 35124527
pmcid: 8940711
Sutin, A. R. et al. Personality and metabolic syndrome. Age (Dordr) 32, 513–519. https://doi.org/10.1007/s11357-010-9153-9 (2010).
doi: 10.1007/s11357-010-9153-9
pubmed: 20567927
Fok, M. L. et al. Life expectancy at birth and all-cause mortality among people with personality disorder. J. Psychosom. Res. 73, 104–107. https://doi.org/10.1016/j.jpsychores.2012.05.001 (2012).
doi: 10.1016/j.jpsychores.2012.05.001
pubmed: 22789412
Fanning, J. R., Lee, R., Gozal, D., Coussons-Read, M. & Coccaro, E. F. Childhood trauma and parental style: Relationship with markers of inflammation, oxidative stress, and aggression in healthy and personality disordered subjects. Biol. Psychol. 112, 56–65. https://doi.org/10.1016/j.biopsycho.2015.09.003 (2015).
doi: 10.1016/j.biopsycho.2015.09.003
pubmed: 26423894
Ogłodek, E. A., Szota, A. M., Just, M. J., Szromek, A. R. & Araszkiewicz, A. A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity. Pharmacol. Rep. 68, 756–763. https://doi.org/10.1016/j.pharep.2016.03.017 (2016).
doi: 10.1016/j.pharep.2016.03.017
pubmed: 27208878
Ogłodek, E. A., Szota, A. M., Just, M. J., Moś, D. M. & Araszkiewicz, A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacol. Rep. 67, 85–89. https://doi.org/10.1016/j.pharep.2014.08.006 (2015).
doi: 10.1016/j.pharep.2014.08.006
pubmed: 25560580
Wang, T. Y. et al. More inflammation but less brain-derived neurotrophic factor in antisocial personality disorder. Psychoneuroendocrinology 85, 42–48. https://doi.org/10.1016/j.psyneuen.2017.08.006 (2017).
doi: 10.1016/j.psyneuen.2017.08.006
pubmed: 28810156
Tasci, G., Kaya, S., Kalayci, M. & Atmaca, M. Increased ghrelin and decreased leptin levels in patients with antisocial personality disorder. J. Affect. Disord. 317, 22–28. https://doi.org/10.1016/j.jad.2022.08.048 (2022).
doi: 10.1016/j.jad.2022.08.048
pubmed: 36028010
Atmaca, M., Kuloglu, M., Tezcan, E., Gecici, O. & Ustundag, B. Serum cholesterol and leptin levels in patients with borderline personality disorder. Neuropsychobiology 45, 167–171. https://doi.org/10.1159/000063665 (2002).
doi: 10.1159/000063665
pubmed: 12097803
Ramirez, A. Young Adults in General Psychiatry (Uppsala University, 2011).
Spitzer, R. L. Psychiatric diagnosis: Are clinicians still necessary?. Compr. Psychiatry 24, 399–411 (1983).
doi: 10.1016/0010-440X(83)90032-9
pubmed: 6354575
First, M. B., Spitzer, R., Gibbon, M. & Williams, J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinical version (SCID-I-CV) (American Psychiatric Press, 1996).
First, M. B., Spitzer, R., Gibbon, M., Williams, J. & Benjamin, L. S. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) (American Psychiatric Press, 1997).
Spangenberg, H., Ramklint, M. & Ramirez, A. Long-term stability of personality traits in a clinical psychiatric sample. Nord. J. Psychiatry 73, 309–316. https://doi.org/10.1080/08039488.2019.1623316 (2019).
doi: 10.1080/08039488.2019.1623316
pubmed: 31304872
Gustavsson, J. P. et al. Swedish universities Scales of Personality (SSP): Construction, internal consistency and normative data. Acta Psychiatr. Scand. 102, 217–225 (2000).
doi: 10.1034/j.1600-0447.2000.102003217.x
pubmed: 11008858
Svanborg, P. & Asberg, M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 89, 21–28 (1994).
doi: 10.1111/j.1600-0447.1994.tb01480.x
pubmed: 8140903
Spitzer, R. L., Williams, J. B., Gibbon, M. & First, M. B. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II) (New York State Psychiatric Department, 1989).
Just, D. et al. Autoantibodies against the C-terminus of Lipopolysaccharide binding protein are elevated in young adults with psychiatric disease. Psychoneuroendocrinology 126, 105162. https://doi.org/10.1016/j.psyneuen.2021.105162 (2021).
doi: 10.1016/j.psyneuen.2021.105162
pubmed: 33578084
Sundberg, I., Lannergård, A., Ramklint, M. & Cunningham, J. L. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: A prospective observational study. BMC Psychiatry 18, 157. https://doi.org/10.1186/s12888-018-1735-6 (2018).
doi: 10.1186/s12888-018-1735-6
pubmed: 29843679
pmcid: 5975521
Byrt, T., Bishop, J. & Carlin, J. B. Bias, prevalence and kappa. J. Clin. Epidemiol. 46, 423–429. https://doi.org/10.1016/0895-4356(93)90018-v (1993).
doi: 10.1016/0895-4356(93)90018-v
pubmed: 8501467
Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295. https://doi.org/10.1056/nejm199602013340503 (1996).
doi: 10.1056/nejm199602013340503
pubmed: 8532024
Shah, N. R. & Braverman, E. R. Measuring adiposity in patients: The utility of body mass index (BMI), percent body fat, and leptin. PLoS ONE 7, e33308. https://doi.org/10.1371/journal.pone.0033308 (2012).
doi: 10.1371/journal.pone.0033308
pubmed: 22485140
pmcid: 3317663
Ghadge, A. A. & Khaire, A. A. Leptin as a predictive marker for metabolic syndrome. Cytokine 121, 154735. https://doi.org/10.1016/j.cyto.2019.154735 (2019).
doi: 10.1016/j.cyto.2019.154735
pubmed: 31154250
Kahl, K. G. et al. Prevalence of the metabolic syndrome in patients with borderline personality disorder: Results from a cross-sectional study. Eur. Arch. Psychiatry Clin. Neurosci. 263, 205–213. https://doi.org/10.1007/s00406-012-0339-2 (2013).
doi: 10.1007/s00406-012-0339-2
pubmed: 22777277
John, A. P., Koloth, R., Dragovic, M. & Lim, S. C. Prevalence of metabolic syndrome among Australians with severe mental illness. Med. J. Aust. 190, 176–179. https://doi.org/10.5694/j.1326-5377.2009.tb02342.x (2009).
doi: 10.5694/j.1326-5377.2009.tb02342.x
pubmed: 19220180
Terracciano, A. et al. Neuroticism, depressive symptoms, and serum BDNF. Psychosom. Med. 73, 638–642. https://doi.org/10.1097/PSY.0b013e3182306a4f (2011).
doi: 10.1097/PSY.0b013e3182306a4f
pubmed: 21949427
pmcid: 3188695
Yasui-Furukori, N. et al. Association between plasma brain-derived neurotrophic factor levels and personality traits in healthy Japanese subjects. Psychiatry Res. 210, 220–223. https://doi.org/10.1016/j.psychres.2013.05.015 (2013).
doi: 10.1016/j.psychres.2013.05.015
pubmed: 23806624
Lee, B. H. & Kim, Y. K. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig. 7, 231–235. https://doi.org/10.4306/pi.2010.7.4.231 (2010).
doi: 10.4306/pi.2010.7.4.231
pubmed: 21253405
pmcid: 3022308
Björkholm, C. & Monteggia, L. M. BDNF: A key transducer of antidepressant effects. Neuropharmacology 102, 72–79. https://doi.org/10.1016/j.neuropharm.2015.10.034 (2016).
doi: 10.1016/j.neuropharm.2015.10.034
pubmed: 26519901
Halaris, A. et al. Serum BDNF: A potential biomarker for major depressive disorder and antidepressant response prediction. J. Depress. Anxiety 4, 2167 (2015).
Quirk, S. E. et al. Population prevalence of personality disorder and associations with physical health comorbidities and health care service utilization: A review. Pers Disord. Theory Res. Treat. 7, 136–146. https://doi.org/10.1037/per0000148 (2016).
doi: 10.1037/per0000148
Moran, P. et al. Personality disorder and cardiovascular disease: Results from a national household survey. J. Clin. Psychiatry 68, 69–74. https://doi.org/10.4088/jcp.v68n0109 (2007).
doi: 10.4088/jcp.v68n0109
pubmed: 17284132
Statens beredning för medicinsk utvärdering. Diagnostik och uppföljning av förstämningssyndrom - en systematisk litteraturöversikt (2012).
Fagerberg, T., Söderman, E., Gustavsson, J. P., Agartz, I. & Jönsson, E. G. Swedish Universities Scales of personality: Relation to other personality instruments. Psychiatry Investig. 18, 373–384. https://doi.org/10.30773/pi.2020.0052 (2021).
doi: 10.30773/pi.2020.0052
pubmed: 33910329
pmcid: 8169328
Fridhandler, B. M. Conceptual note on state, trait, and the state–trait distinction. J. Pers. Soc. Psychol. 50, 169 (1986).
doi: 10.1037/0022-3514.50.1.169
Aluoja, A. et al. Personality traits measured by the Swedish universities scales of personality: Factor structure and position within the five-factor model in an Estonian sample. Nord. J. Psychiatry 63, 231–236. https://doi.org/10.1080/08039480802571036 (2009).
doi: 10.1080/08039480802571036
pubmed: 19034803
Mattila-Evenden, M., Svanborg, P., Gustavsson, P. & Asberg, M. Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of the CPRS. Acta Psychiatr. Scand. 94, 386–396. https://doi.org/10.1111/j.1600-0447.1996.tb09879.x (1996).
doi: 10.1111/j.1600-0447.1996.tb09879.x
pubmed: 9020988